Investigation Report on China Polyene Phosphatidyl Choline Market, 2010-2019
Description
China is recognized worldwide as one of the countries with a high incidence of liver disease. Viral hepatitis, fatty liver, alcoholic liver disease, medicamentous liver lesion and liver cancer have posed a severe threat to Chinese people’s health. In recent years, drugs for liver disease that rank second to proton pump inhibitor in drugs for digestive system have gradually become a variety with large sales value which occupies 30% of the total sales value of all ten categories of drugs for digestive system.
Among all the drugs for liver disease, polyene phosphatidyl choline is the natural diglyceride of cholinephosphoric acid and unsaturated fatty acids which can protect hepatocyte from lesion, alleviate inflammation reaction and improve the detoxification of the liver. And it is used for the treatment of hepatitis (acute and chronic), hepatic cirrhosis and poisoning with certain efficacy in the clinic. First developed by Sanofi, polyene phosphatidyl choline has been marketed under the trade name of Essentiale Forte.
Some local enterprises are already capable of producing polyene phosphatidyl choline APIs and injections. For example, Sichuan Haisco Pharmaceutical Co., Ltd and Chengdu Tiantaishan Pharmaceutical Co., Ltd have been approved to produce polyene phosphatidyl choline under the trade name of Yibisheng. Imported drugs mainly come from Sanofi (Beijing), Shenzhen Sanofi Pasteur Biological Products Co., Ltd, Sanofi-Aventis Ukraine LLc and A.Nattermann & Cie.GmbH.
The growth of polyene phosphatidyl choline has accelerated since 2006, making it occupy an important proportion of the adjuvant drugs for liver disease. According to CRI’s survey, the sales value of polyene phosphatidyl choline in sample hospitals rose from less than CNY 60 million in 2005 to over CNY 400 million in 2014 and CAGR during this period reached 25%. Chengdu Tiantaishan Pharmaceutical Co., Ltd, Shenzhen Sanofi Pasteur Biological Products Co., Ltd, Hangzhou Sanofi-Synthelabo Minsheng Pharmaceutical Co., Ltd and Aventis Pharma S.p.A.(SP) occupy the majority of market share, among which Chengdu Tiantaishan Pharmaceutical Co., Ltd had the largest market share of about 60% for sales value in 2014.
With the lifestyle changes brought about economic development, the incidence of liver disease in China has kept increasing. Therefore, the market size of polyene phosphatidyl choline is expected to continue to grow in the next few years in China.
Readers can get at least the following information from this report:
China is recognized worldwide as one of the countries with a high incidence of liver disease. Viral hepatitis, fatty liver, alcoholic liver disease, medicamentous liver lesion and liver cancer have posed a severe threat to Chinese people’s health. In recent years, drugs for liver disease that rank second to proton pump inhibitor in drugs for digestive system have gradually become a variety with large sales value which occupies 30% of the total sales value of all ten categories of drugs for digestive system.
Among all the drugs for liver disease, polyene phosphatidyl choline is the natural diglyceride of cholinephosphoric acid and unsaturated fatty acids which can protect hepatocyte from lesion, alleviate inflammation reaction and improve the detoxification of the liver. And it is used for the treatment of hepatitis (acute and chronic), hepatic cirrhosis and poisoning with certain efficacy in the clinic. First developed by Sanofi, polyene phosphatidyl choline has been marketed under the trade name of Essentiale Forte.
Some local enterprises are already capable of producing polyene phosphatidyl choline APIs and injections. For example, Sichuan Haisco Pharmaceutical Co., Ltd and Chengdu Tiantaishan Pharmaceutical Co., Ltd have been approved to produce polyene phosphatidyl choline under the trade name of Yibisheng. Imported drugs mainly come from Sanofi (Beijing), Shenzhen Sanofi Pasteur Biological Products Co., Ltd, Sanofi-Aventis Ukraine LLc and A.Nattermann & Cie.GmbH.
The growth of polyene phosphatidyl choline has accelerated since 2006, making it occupy an important proportion of the adjuvant drugs for liver disease. According to CRI’s survey, the sales value of polyene phosphatidyl choline in sample hospitals rose from less than CNY 60 million in 2005 to over CNY 400 million in 2014 and CAGR during this period reached 25%. Chengdu Tiantaishan Pharmaceutical Co., Ltd, Shenzhen Sanofi Pasteur Biological Products Co., Ltd, Hangzhou Sanofi-Synthelabo Minsheng Pharmaceutical Co., Ltd and Aventis Pharma S.p.A.(SP) occupy the majority of market share, among which Chengdu Tiantaishan Pharmaceutical Co., Ltd had the largest market share of about 60% for sales value in 2014.
With the lifestyle changes brought about economic development, the incidence of liver disease in China has kept increasing. Therefore, the market size of polyene phosphatidyl choline is expected to continue to grow in the next few years in China.
Readers can get at least the following information from this report:
- market size of polyene phosphatidyl choline in China
- competitive landscape of polyene phosphatidyl choline in Chinese market
- price of polyene phosphatidyl choline made by different enterprises in China
- market outlook of polyene phosphatidyl choline in China
- manufacturers of drugs for liver disease
- investors/ research institutions interested in Chinese medicine market
- any interest in the Chinese medicine market, please contact CRI for customized survey service
1 RELATED CONCEPTS OF POLYENE PHOSPHATIDYL CHOLINE
1.1 Indication
1.2 Sales Status in Global Market
2 MARKET PROFILE OF POLYENE PHOSPHATIDYL CHOLINE IN CHINA
2.1 Patent and Approval Status of Polyene Phosphatidyl Choline in China
2.2 Major Manufacturers
2.3 Market Size
3 SURVEY ON SALES STATUS OF POLYENE PHOSPHATIDYL CHOLINE IN CHINA, 2010-2014
3.1 Sales Value
3.1.1 Overall Sales Value
3.1.2 Sales Value by Regions
3.2 Sales Volume
3.2.1 Overall Sales Volume
3.2.2 Sales Volume by Regions
4 SURVEY ON MARKET SHARE OF MAJOR MANUFACTURERS OF POLYENE PHOSPHATIDYL CHOLINE IN CHINA, 2010-2014
4.1 Market Share by Sales Value
4.2 Market Share by Sales Volume
5 SURVEY ON DOSAGE FORMS OF POLYENE PHOSPHATIDYL CHOLINE IN CHINA, 2010-2014
5.1 Share of Different Dosage Forms by Sales Value
5.2 Share of Different Dosage Forms by Sales Volume
6 REFERENCE PRICE OF POLYENE PHOSPHATIDYL CHOLINE IN CHINESE HOSPITALS IN 2014
6.1 Aventis Pharma S.p.A.(SP) (Trade Name: Essentiale Forte)
6.2 Chengdu Tiantaishan Pharmaceutical Co., Ltd (Trade Name: Yibisheng)
6.3 Hangzhou Sanofi-Synthelabo Minsheng Pharmaceutical Co., Ltd
6.4 Shenzhen Sanofi Pasteur Biological Products Co., Ltd (Trade Name: Essentiale Forte)
7 MAJOR MANUFACTURERS OF POLYENE PHOSPHATIDYL CHOLINE IN CHINESE MARKET, 2010-2014
7.1 Shenzhen Sanofi Pasteur Biological Products Co., Ltd
7.2 Hangzhou Sanofi-Synthelabo Minsheng Pharmaceutical Co., Ltd
7.3 Chengdu Tiantaishan Pharmaceutical Co., Ltd
7.4 Aventis Pharma S.p.A.
8 MARKET OUTLOOK OF POLYENE PHOSPHATIDYL CHOLINE IN CHINA, 2015-2019
8.1 Forecast of Market Size
8.2 Forecast of Competitive Landscape
TABLE OF SELECTED CHARTS
Chart Approval Information of Polyene Phosphatidyl Choline in China
Chart Sales Status of Polyene Phosphatidyl Choline in China
Chart Sales Value of Polyene Phosphatidyl Choline in China, 2010-2014
Chart Sales Value of Polyene Phosphatidyl Choline in Some Regions in China, 2010-2014
Chart Sales Volume of Polyene Phosphatidyl Choline in China, 2010-2014
Chart Market Share of TOP3 Manufacturers of Polyene Phosphatidyl Choline for Sales Value in China, 2010-2014
Chart Sales Value and Market Share of Polyene Phosphatidyl Choline Made by Chengdu Tiantaishan in China, 2010-2014
Chart Sales Value and Market Share of Polyene Phosphatidyl Choline Made by Hangzhou Sanofi-Synthelabo Minsheng in China, 2010-2014
Chart Sales Value and Market Share of Polyene Phosphatidyl Choline Made by Aventis(SP) in China, 2010-2014
Chart Sales Value and Market Share of Polyene Phosphatidyl Choline Made by Other Enterprises in China, 2010-2014
Chart Sales Value and Market Share of Polyene Phosphatidyl Choline Injections in China, 2010-2014
Chart Sales Value and Market Share of Polyene Phosphatidyl Choline Capsules in China, 2010-2014
Chart Price of Polyene Phosphatidyl Choline Made by Aventis Pharma S.p.A.(SP) in Some Chinese Cities in 2014
Chart Price of Polyene Phosphatidyl Choline Made by Chengdu Tiantaishan Pharmaceutical Co., Ltd in Some Chinese Cities in 2014
Chart Price of Polyene Phosphatidyl Choline Made by Hangzhou Sanofi-Synthelabo Minsheng Pharmaceutical Co., Ltd in Some Chinese Cities in 2014
Chart Price of Polyene Phosphatidyl Choline Made by Shenzhen Sanofi Pasteur Biological Products Co., Ltd in Some Chinese Cities in 2014
1.1 Indication
1.2 Sales Status in Global Market
2 MARKET PROFILE OF POLYENE PHOSPHATIDYL CHOLINE IN CHINA
2.1 Patent and Approval Status of Polyene Phosphatidyl Choline in China
2.2 Major Manufacturers
2.3 Market Size
3 SURVEY ON SALES STATUS OF POLYENE PHOSPHATIDYL CHOLINE IN CHINA, 2010-2014
3.1 Sales Value
3.1.1 Overall Sales Value
3.1.2 Sales Value by Regions
3.2 Sales Volume
3.2.1 Overall Sales Volume
3.2.2 Sales Volume by Regions
4 SURVEY ON MARKET SHARE OF MAJOR MANUFACTURERS OF POLYENE PHOSPHATIDYL CHOLINE IN CHINA, 2010-2014
4.1 Market Share by Sales Value
4.2 Market Share by Sales Volume
5 SURVEY ON DOSAGE FORMS OF POLYENE PHOSPHATIDYL CHOLINE IN CHINA, 2010-2014
5.1 Share of Different Dosage Forms by Sales Value
5.2 Share of Different Dosage Forms by Sales Volume
6 REFERENCE PRICE OF POLYENE PHOSPHATIDYL CHOLINE IN CHINESE HOSPITALS IN 2014
6.1 Aventis Pharma S.p.A.(SP) (Trade Name: Essentiale Forte)
6.2 Chengdu Tiantaishan Pharmaceutical Co., Ltd (Trade Name: Yibisheng)
6.3 Hangzhou Sanofi-Synthelabo Minsheng Pharmaceutical Co., Ltd
6.4 Shenzhen Sanofi Pasteur Biological Products Co., Ltd (Trade Name: Essentiale Forte)
7 MAJOR MANUFACTURERS OF POLYENE PHOSPHATIDYL CHOLINE IN CHINESE MARKET, 2010-2014
7.1 Shenzhen Sanofi Pasteur Biological Products Co., Ltd
7.2 Hangzhou Sanofi-Synthelabo Minsheng Pharmaceutical Co., Ltd
7.3 Chengdu Tiantaishan Pharmaceutical Co., Ltd
7.4 Aventis Pharma S.p.A.
8 MARKET OUTLOOK OF POLYENE PHOSPHATIDYL CHOLINE IN CHINA, 2015-2019
8.1 Forecast of Market Size
8.2 Forecast of Competitive Landscape
TABLE OF SELECTED CHARTS
Chart Approval Information of Polyene Phosphatidyl Choline in China
Chart Sales Status of Polyene Phosphatidyl Choline in China
Chart Sales Value of Polyene Phosphatidyl Choline in China, 2010-2014
Chart Sales Value of Polyene Phosphatidyl Choline in Some Regions in China, 2010-2014
Chart Sales Volume of Polyene Phosphatidyl Choline in China, 2010-2014
Chart Market Share of TOP3 Manufacturers of Polyene Phosphatidyl Choline for Sales Value in China, 2010-2014
Chart Sales Value and Market Share of Polyene Phosphatidyl Choline Made by Chengdu Tiantaishan in China, 2010-2014
Chart Sales Value and Market Share of Polyene Phosphatidyl Choline Made by Hangzhou Sanofi-Synthelabo Minsheng in China, 2010-2014
Chart Sales Value and Market Share of Polyene Phosphatidyl Choline Made by Aventis(SP) in China, 2010-2014
Chart Sales Value and Market Share of Polyene Phosphatidyl Choline Made by Other Enterprises in China, 2010-2014
Chart Sales Value and Market Share of Polyene Phosphatidyl Choline Injections in China, 2010-2014
Chart Sales Value and Market Share of Polyene Phosphatidyl Choline Capsules in China, 2010-2014
Chart Price of Polyene Phosphatidyl Choline Made by Aventis Pharma S.p.A.(SP) in Some Chinese Cities in 2014
Chart Price of Polyene Phosphatidyl Choline Made by Chengdu Tiantaishan Pharmaceutical Co., Ltd in Some Chinese Cities in 2014
Chart Price of Polyene Phosphatidyl Choline Made by Hangzhou Sanofi-Synthelabo Minsheng Pharmaceutical Co., Ltd in Some Chinese Cities in 2014
Chart Price of Polyene Phosphatidyl Choline Made by Shenzhen Sanofi Pasteur Biological Products Co., Ltd in Some Chinese Cities in 2014
